第 1 到 40 筆結果,共 40 筆。
公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 | |
---|---|---|---|---|---|---|---|
1 | 2023 | Effects of Early Short-Course Corticosteroids on Immune-Related Adverse Events in Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors | DE-RUI HUANG ; BIN-CHI LIAO ; Hsu, Wei-Hsun; CHING-YAO YANG ; YEN-TING LIN ; SHANG-GIN WU ; TZU-HSIU TSAI ; KUAN-YU CHEN ; CHAO-CHI HO ; WEI-YU LIAO ; JIN-YUAN SHIH ; CHONG-JEN YU ; CHIH-HSIN YANG ; ANN-LII CHENG ; YING-CHUN SHEN | Oncology | |||
2 | 2023 | Oral uracil–tegafur compared with intravenous chemotherapy as adjuvant therapy for resected early-stage non-small cell lung cancer patients | SHENG-KAI LIANG ; Wu, Chang-Wei; Chang, Ching-I; LI-TA KENG ; MENG-RUI LEE ; JANN-YUAN WANG ; JEN-CHUNG KO ; WEI-YU LIAO ; KUAN-YU CHEN ; CHAO-CHI HO ; JIN-YUAN SHIH ; CHONG-JEN YU | Cancer medicine | 0 | 0 | |
3 | 2023 | Lung adenocarcinoma with neuroendocrine differentiation: Molecular markers testing and treatment outcomes | HAO-CHUN CHANG ; KUAN-YU CHEN ; YIH-LEONG CHANG ; JIN-YUAN SHIH ; CHONG-JEN YU | Journal of the Formosan Medical Association = Taiwan yi zhi | 2 | 0 | |
4 | 2022 | Real-world treatment patterns and outcomes among patients with advanced non-small-cell lung cancer with spindle cell and/or giant cell carcinoma | CHIA-LING CHANG ; MIN-SHU HSIEH ; JIN-YUAN SHIH ; Lee, Yi-Hsuan; WEI-YU LIAO ; CHIA-LIN HSU ; CHING-YAO YANG ; KUAN-YU CHEN ; JIH-HSIANG LEE ; CHAO-CHI HO ; TZU-HSIU TSAI ; CHIH-HSIN YANG ; CHONG-JEN YU | Therapeutic advances in medical oncology | 1 | 1 | |
5 | 2021 | Monitoring levels of vimentin-positive circulating cancer stem cells and tumor cells in patients with advanced EGFR-mutated non-small cell lung cancer | CHIA-LIN HSU ; TZU-HSIU TSAI ; CHUN-KAI HUANG ; CHING-YAO YANG ; WEI-YU LIAO ; CHAO-CHI HO ; SHENG-YUAN RUAN ; KUAN-YU CHEN ; JIN-YUAN SHIH ; PAN-CHYR YANG | Lung cancer (Amsterdam, Netherlands) | 5 | 5 | |
6 | 2020 | Clinical factors associated with treatment toxicity of pemetrexed plus platinum in elderly patients with non-small cell lung cancer | CHUNG-YU CHEN ; KUAN-YU CHEN ; JIN-YUAN SHIH ; CHONG-JEN YU | Journal of the Formosan Medical Association | 5 | 4 | |
7 | 2020 | Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors | CHING-YAO YANG ; WEI-YU LIAO ; CHAO-CHI HO ; KUAN-YU CHEN ; TZU-HSIU TSAI ; CHIA-LIN HSU ; KANG-YI SU ; YIH-LEONG CHANG ; CHEN-TU WU ; Chia-Chi Hsu; BIN-CHI LIAO ; Wei-Hsun Hsu; JIH-HSIANG LEE ; CHIA-CHI LIN ; JIN-YUAN SHIH ; CHIH-HSIN YANG ; CHONG-JEN YU | European Journal of Cancer | 55 | 49 | |
8 | 2020 | Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib | CHING-YAO YANG ; WEI-YU LIAO ; CHAO-CHI HO ; KUAN-YU CHEN ; TZU-HSIU TSAI ; CHIA-LIN HSU ; Liu, Yi-Nan; KANG-YI SU ; YIH-LEONG CHANG ; CHEN-TU WU ; BIN-CHI LIAO ; Hsu, Chia-Chi; Hsu, Wei-Hsun; JIH-HSIANG LEE ; CHIA-CHI LIN ; JIN-YUAN SHIH ; CHIH-HSIN YANG ; CHONG-JEN YU | Oncologist | 15 | 15 | |
9 | 2019 | Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations | YEN-TING LIN ; JIN-SHING CHEN ; WEI-YU LIAO ; CHAO-CHI HO ; CHIA-LIN HSU ; Yang C.-Y.; KUAN-YU CHEN ; JIH-HSIANG LEE ; ZHONG-ZHE LIN ; JIN-YUAN SHIH ; CHIH-HSIN YANG ; CHONG-JEN YU | International Journal of Cancer | 53 | 46 | |
10 | 2019 | Incidence of hepatitis B reactivation during epidermal growth factor receptor tyrosine kinase inhibitor treatment in non–small-cell lung cancer patients | ZONG-HAN YAO ; WEI-YU LIAO ; CHAO-CHI HO ; KUAN-YU CHEN ; JIN-YUAN SHIH ; JIN-SHING CHEN ; ZHONG-ZHE LIN ; CHIA-CHI LIN ; CHIH-HSIN YANG ; CHONG-JEN YU | European Journal of Cancer | 27 | 24 | |
11 | 2019 | Non-small cell lung cancer harbouring non-resistant uncommon EGFR mutations: Mutation patterns, effectiveness of epidermal growth factor receptor-tyrosine kinase inhibitors and prognostic factors | LIH-CHYUN CHANG ; Lim, Chor-Kuan; LIH-YU CHANG ; KUAN-YU CHEN ; JIN-YUAN SHIH ; CHONG-JEN YU | European Journal of Cancer | 22 | 19 | |
12 | 2019 | Cranial Irradiation for Patients with Epidermal Growth Factor Receptor (EGFR) Mutant Lung Cancer Who Have Brain Metastases in the Era of a New Generation of EGFR Inhibitors | JIH-HSIANG LEE ; Chen H.-Y.; Feng-Ming Hsu ; JIN-SHING CHEN ; WEI-YU LIAO ; JIN-YUAN SHIH ; CHONG-JEN YU ; KUAN-YU CHEN ; TZU-HSIU TSAI ; CHIH-HSIN YANG | Oncologist | 20 | 18 | |
13 | 2018 | Combined effect of ERCC1 and ERCC2 polymorphisms on overall survival in non-squamous non-small-cell lung cancer patients treated with first-line pemetrexed/platinum | WEI-YU LIAO ; CHAO-CHI HO ; TZU-HSIU TSAI ; KUAN-YU CHEN ; JIN-YUAN SHIH ; CHONG-JEN YU | Lung Cancer | 14 | 11 | |
14 | 2018 | Treatment effectiveness and tolerability of afatinib at different doses in patients with EGFR-mutated lung adenocarcinoma: How low can we go? | Lim C.-K.; Wei Y.-F.; Tsai M.-S.; KUAN-YU CHEN ; JIN-YUAN SHIH ; CHONG-JEN YU | European Journal of Cancer | 18 | 14 | |
15 | 2018 | Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan | SHU-YUNG LIN ; Yang C.-Y.; BIN-CHI LIAO ; CHAO-CHI HO ; WEI-YU LIAO ; KUAN-YU CHEN ; TZU-HSIU TSAI ; CHIA-LIN HSU ; Hsu W.-H.; KANG-YI SU ; YIH-LEONG CHANG ; JIH-HSIANG LEE ; CHIA-CHI LIN ; JIN-YUAN SHIH ; CHIH-HSIN YANG ; CHONG-JEN YU | Journal of Cancer | 40 | 41 | |
16 | 2018 | Epidermal growth factor receptor mutation predicts favorable outcomes in non-small cell lung cancer patients with brain metastases treated with stereotactic radiosurgery | WEN-CHI YANG ; FU-REN XIAO ; JIN-YUAN SHIH ; CHAO-CHI HO ; YA-FANG CHEN ; Tseng H.-M.; KUAN-YU CHEN ; WEI-YU LIAO ; CHONG-JEN YU ; CHIH-HSIN YANG ; SUNG-HSIN KUO ; CHIA-HSIEN CHENG ; PAN-CHYR YANG ; FENG-MING HSU | Radiotherapy and Oncology | 22 | 21 | |
17 | 2017 | Expression of notch gene and its impact on survival of patients with resectable non-small cell lung cancer | CHUNG-YU CHEN ; Chen Y.-Y.; MIN-SHU HSIEH ; CHAO-CHI HO ; KUAN-YU CHEN ; JIN-YUAN SHIH ; CHONG-JEN YU | Journal of Cancer | 25 | 23 | |
18 | 2017 | Real-world data on prognostic factors for overall survival in EGFR mutation-positive advanced non-small cell lung cancer patients treated with first-line gefitinib | ZONG-HAN YAO ; WEI-YU LIAO ; CHAO-CHI HO ; KUAN-YU CHEN ; JIN-YUAN SHIH ; JIN-SHING CHEN ; ZHONG-ZHE LIN ; Chia-Chi Lin ; CHIH-HSIN YANG ; CHONG-JEN YU | Oncologist | 25 | 25 | |
19 | 2017 | Outcomes of cancer therapy administered to treatment-naïve lung cancer patients in the intensive care unit | YEN-FU CHEN ; JOU-WEI LIN ; CHAO-CHI HO ; CHING-YAO YANG ; CHIA-HAO CHANG ; TAO-MIN HUANG ; CHUNG-YU CHEN ; KUAN-YU CHEN ; JIN-YUAN SHIH ; CHONG-JEN YU | Journal of Cancer | 18 | 11 | |
20 | 2017 | Astrocyte-elevated gene-1 confers resistance to pemetrexed in non-small cell lung cancer by upregulating thymidylate synthase expression | CHUNG-YU CHEN ; Chen Y.-Y.; Chen J.J.W.; KUAN-YU CHEN ; CHAO-CHI HO ; JIN-YUAN SHIH ; YIH-LEONG CHANG ; CHONG-JEN YU ; PAN-CHYR YANG | Oncotarget | 9 | 9 | |
21 | 2017 | Coexistence of the BRAF Mutation and EGFR Exon 20 Insertion in a Patient with Lung Adenocarcinoma | LIH-CHYUN CHANG ; KUAN-YU CHEN ; JIN-YUAN SHIH ; CHONG-JEN YU ; MIN-SHU HSIEH | Journal of Thoracic Oncology | 1 | 0 | |
22 | 2015 | Identification of Five Driver Gene Mutations in Patients with Treatment-Naïve Lung Adenocarcinoma in Taiwan | Hsu K.-H.; CHAO-CHI HO ; Hsia T.-C.; Tseng J.-S.; KANG-YI SU ; Wu M.-F.; Chiu K.-L.; Yang T.-Y.; Chen K.-C.; Ooi H.; Wu T.-C.; Chen H.-J.; Chen H.-Y.; Chang C.-S.; Hsu C.-P.; Hsia J.-Y.; Chuang C.-Y.; Lin C.-H.; Chen J.J.W.; KUAN-YU CHEN ; WEI-YU LIAO ; JIN-YUAN SHIH ; SUNG-LIANG YU ; CHONG-JEN YU ; PAN-CHYR YANG ; Chang G.-C. | PLoS ONE | 98 | 92 | |
23 | 2015 | Estimated creatinine clearance rate is associated with the treatment effectiveness and toxicity of pemetrexed as continuation maintenance therapy for advanced nonsquamous non-small-cell lung cancer | CHUNG-YU CHEN ; JOU-WEI LIN ; JENQ-WEN HUANG ; KUAN-YU CHEN ; JIN-YUAN SHIH ; CHONG-JEN YU ; PAN-CHYR YANG | Clinical Lung Cancer | 11 | 10 | |
24 | 2015 | EGFR mutation and lobar location of lung adenocarcinoma | Tseng C.-H.; Chen K.-C.; Hsu K.-H.; Tseng J.-S.; CHAO-CHI HO ; Hsia T.-C.; KANG-YI SU ; Wu M.-F.; Chiu K.-L.; Liu C.-M.; Wu T.-C.; Chen H.-J.; Chen H.-Y.; Chang C.-S.; Hsu C.-P.; Hsia J.-Y.; Chuang C.-Y.; Lin C.-H.; Chen J.J.W.; KUAN-YU CHEN ; WEI-YU LIAO ; JIN-YUAN SHIH ; SUNG-LIANG YU ; CHONG-JEN YU ; PAN-CHYR YANG ; Yang T.-Y.; Chang G.-C. | Carcinogenesis | 13 | 12 | |
25 | 2015 | Advanced non-small cell lung cancer in the elderly: The impact of age and comorbidities on treatment modalities and patient prognosis | CHIA-LIN HSU ; JEN-HAU CHEN ; KUAN-YU CHEN ; JIN-YUAN SHIH ; CHIH-HSIN YANG ; CHONG-JEN YU ; PAN-CHYR YANG | Journal of Geriatric Oncology | 35 | 34 | |
26 | 2014 | Bcl-2-like protein 11 deletion polymorphism predicts survival in advanced non-small-cell lung cancer | JIH-HSIANG LEE ; Lin Y.-L.; Hsu W.-H.; Chen H.-Y.; YEUN-CHUNG CHANG ; CHONG-JEN YU ; JIN-YUAN SHIH ; CHIA-CHI LIN ; KUAN-YU CHEN ; CHAO-CHI HO ; WEI-YU LIAO ; PAN-CHYR YANG ; CHIH-HSIN YANG | Journal of Thoracic Oncology | 44 | 35 | |
27 | 2013 | Neoadjuvant chemotherapy with docetaxel-cisplatin in patients with stage III N2 non-small-cell lung cancer | WEI-YU LIAO ; Chen J.-H.; Wu M.; JIN-YUAN SHIH ; KUAN-YU CHEN ; CHAO-CHI HO ; CHIH-HSIN YANG ; CHONG-JEN YU | Clinical Lung Cancer | 22 | 20 | |
28 | 2013 | Multi-gene analyses from waste brushing specimens for patients with peripheral lung cancer receiving EBUS-assisted bronchoscopy | TZU-HSIU TSAI ; CHING-YAO YANG ; CHAO-CHI HO ; WEI-YU LIAO ; I-SHIOW JAN ; KUAN-YU CHEN ; JANN-YUAN WANG ; SHENG-YUAN RUAN ; CHONG-JEN YU ; CHIH-HSIN YANG ; PAN-CHYR YANG ; JIN-YUAN SHIH | Lung Cancer | 33 | 30 | |
29 | 2012 | Advanced non-small cell lung cancer in patients aged 45 years or younger: Outcomes and prognostic factors | CHIA-LIN HSU ; KUAN-YU CHEN ; JIN-YUAN SHIH ; CHAO-CHI HO ; CHIH-HSIN YANG ; CHONG-JEN YU ; PAN-CHYR YANG | BMC Cancer | 72 | 66 | |
30 | 2011 | The prognostic value of the simplified comorbidity score in the treatment of small cell lung carcinoma | YAO-WEN KUO ; JIH-SHUIN JERNG ; JIN-YUAN SHIH ; KUAN-YU CHEN ; CHONG-JEN YU ; PAN-CHYR YANG | Journal of Thoracic Oncology | 26 | 24 | |
31 | 2011 | Gefitinib therapy in patients with advanced non-small cell lung cancer with or without testing for epidermal growth factor receptor (EGFR) mutations | Wu J.-Y.; JIN-YUAN SHIH ; KUAN-YU CHEN ; CHIH-HSIN YANG ; CHONG-JEN YU ; PAN-CHYR YANG | Medicine | 32 | 27 | |
32 | 2011 | Thymidylate synthase and dihydrofolate reductase expression in non-small cell lung carcinoma: The association with treatment efficacy of pemetrexed | CHUNG-YU CHEN ; YIH-LEONG CHANG ; JIN-YUAN SHIH ; JOU-WEI LIN ; KUAN-YU CHEN ; CHIH-HSIN YANG ; CHONG-JEN YU ; PAN-CHYR YANG | Lung Cancer | 108 | 102 | |
33 | 2010 | Octogenarians with advanced non-small cell lung cancer: Treatment modalities, survival, and prognostic factors | KUAN-YU CHEN ; JEN-HAU CHEN ; JIN-YUAN SHIH ; CHIH-HSIN YANG ; CHONG-JEN YU ; PAN-CHYR YANG | Journal of Thoracic Oncology | 17 | 14 | |
34 | 2010 | Pemetrexed for heavily pretreated patients with advanced non-small cell lung cancer | JIH-HSIANG LEE ; CHONG-JEN YU ; KUAN-YU CHEN ; JIN-YUAN SHIH ; Lin Y.-L.; CHIH-HSIN YANG | Journal of the Formosan Medical Association | 6 | 5 | |
35 | 2010 | Second-line treatments after first-line gefitinib therapy in advanced nonsmall cell lung cancer | Wu J.-Y.; JIN-YUAN SHIH ; CHIH-HSIN YANG ; KUAN-YU CHEN ; CHAO-CHI HO ; CHONG-JEN YU ; PAN-CHYR YANG | International Journal of Cancer | 53 | 45 | |
36 | 2009 | EGFR intron 1 dinucleotide repeat polymorphism is associated with the occurrence of skin rash with gefitinib treatment | Huang C.-L.; CHIH-HSIN YANG ; KUN-HUEI YEH ; Hu F.-C.; KUAN-YU CHEN ; JIN-YUAN SHIH ; ZHONG-ZHE LIN ; CHONG-JEN YU ; ANN-LII CHENG ; PAN-CHYR YANG | Lung Cancer | 43 | 36 | |
37 | 2008 | Specific EGFR mutations predict treatment outcome of stage IIIB/IV patients with chemotherapy-naive non-small-cell lung cancer receiving first-line gefitinib monotherapy | CHIH-HSIN YANG ; CHONG-JEN YU ; JIN-YUAN SHIH ; YEUN-CHUNG CHANG ; Hu F.-C.; Tsai M.-C.; KUAN-YU CHEN ; ZHONG-ZHE LIN ; Huang C.-J.; CHIA-TUNG SHUN ; Huang C.-L.; Bean J.; ANN-LII CHENG ; Pao W.; PAN-CHYR YANG | Journal of Clinical Oncology | 240 | 224 | |
38 | 2006 | Epidermal growth factor receptor mutations in needle biopsy/aspiration samples predict response to gefitinib therapy and survival of patients with advanced nonsmall cell lung cancer | JIN-YUAN SHIH ; Gow C.-H.; CHONG-JEN YU ; CHIH-HSIN YANG ; YIH-LEONG CHANG ; Tsai M.-F.; Hsu Y.-C.; KUAN-YU CHEN ; Su W.-P.; PAN-CHYR YANG | International Journal of Cancer | 154 | 142 | |
39 | 1998 | Primary pulmonary plasmacytoma with lobar consolidation: An unusual presentation | KUAN-YU CHEN ; Wu H.-D.; YIH-LEONG CHANG ; JIN-YUAN SHIH ; PAN-CHYR YANG | Journal of the Formosan Medical Association | 12 | 8 | |
40 | 1998 | Lung cancer in pregnancy: Report of two cases | KUAN-YU CHEN ; HAO-CHIEN WANG ; JIN-YUAN SHIH ; PAN-CHYR YANG | Journal of the Formosan Medical Association | 10 | 8 |